• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

News

Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia

19 de March de 2017
Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):E2911-E2919. doi:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-03-19 10:00:002017-03-19 10:00:00Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia

Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells

28 de February de 2017
Oncogenesis. 2017 Feb 27;6(2):e299. doi: 10.1038/oncsis.2017.4.ABSTRACTFatty…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-02-28 11:00:002017-02-28 11:00:00Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells

Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users

18 de February de 2017
Nutrients. 2017 Feb 10;9(2):121. doi: 10.3390/nu9020121.ABSTRACTMetabolic…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-02-18 11:00:002017-02-18 11:00:00Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users

AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy

12 de February de 2017
J Invest Dermatol. 2017 Jun;137(6):1297-1310. doi: 10.1016/j.jid.2017.01.021.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-02-12 11:00:002017-02-12 11:00:00AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy

Nuclear reprogramming of cancer stem cells: Corrupting the epigenetic code of cell identity with oncometabolites

17 de January de 2017
Mol Cell Oncol. 2016 Mar 28;3(6):e1160854. doi: 10.1080/23723556.2016.1160854.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-01-17 11:00:002017-01-17 11:00:00Nuclear reprogramming of cancer stem cells: Corrupting the epigenetic code of cell identity with oncometabolites

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition

20 de December de 2016
Oncogene. 2017 May 11;36(19):2737-2749. doi: 10.1038/onc.2016.427.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2016-12-20 11:00:002016-12-20 11:00:00Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition

20 de December de 2016
Oncogene. 2017 May 11;36(19):2737-2749. doi: 10.1038/onc.2016.427.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2016-12-20 11:00:002016-12-20 11:00:00Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition

Adult T-cell leukemia/lymphoma

8 de December de 2016
Rev Assoc Med Bras (1992). 2016 Oct;62(7):691-700. doi: 10.1590/1806-9282.62.07.691.ABSTRACTAdult…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2016-12-08 11:00:002016-12-08 11:00:00Adult T-cell leukemia/lymphoma

Antiangiogenic resistance via metabolic symbiosis

19 de November de 2016
Mol Cell Oncol. 2016 Jul 14;3(5):e1211979. doi: 10.1080/23723556.2016.1211979.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2016-11-19 11:00:002016-11-19 11:00:00Antiangiogenic resistance via metabolic symbiosis

Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action

16 de November de 2016
Target Oncol. 2017 Feb;12(1):19-35. doi: 10.1007/s11523-016-0463-4.ABSTRACTRenal…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2016-11-16 11:00:002016-11-16 11:00:00Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action

Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer

9 de November de 2016
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7535-E7544. doi:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2016-11-09 11:00:002016-11-09 11:00:00Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer

Corrigendum: A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect

3 de November de 2016
Nat Commun. 2016 Nov 2;7:13467. doi: 10.1038/ncomms13467.NO ABSTRACTPMID:27804975…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2016-11-03 10:00:002016-11-03 10:00:00Corrigendum: A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect
Page 64 of 88«‹6263646566›»

Filter by categories

  • Alemany’s & Piulats’s lab (135)
  • Antolin's lab (36)
  • Aytes's Lab (25)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (112)
  • Sin categoría (12)
  • Sureda's & Farre's Lab (319)
  • Viñals's lab (114)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}